Skip to main content
. 2012 Dec;24(6):355–358. doi: 10.3969/j.issn.1002-0829.2012.06.009

Figure 2. Results of a GCMM applied to the same data. Treated subjects in class 2 have greater decline than placebo subjects.

Figure 2.